Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Biosimilars Deals 2024
Chris Vindurampulle
Diversity
Intranet
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
Paul Johns
PipCast®
PTE
Trade Marks
Webinars

Pearce IP and its Leaders Ranked in IAM Patent 1000 2023 for Litigation and Prosecution

by | Jul 5, 2023

IAM Patent 1000 2023
We are delighted to announce that Pearce IP, together with three of its leaders have been ranked in IAM Patent 1000 in 2023.  IAM Patent 1000 “shines a spotlight on the firms and individuals that are deemed outstanding in the pivotal area of patent law”.

Pearce IP has been ranked for both patent litigation and patent prosecution, and its leaders have been individually ranked, as follows:

IAM 1000 reported:

“Dedicating itself solely to the life sciences sector, Pearce IP is a unique phenomenon in Australia: it has assembled the premier life sciences patent attorneys and lawyers in the country and ably assists global pharmaceutical and biotechnology players in crucial patent matters. One enthusiastic patron best sums up the outfit: “Pearce IP is a do-it-all global firm. They can operate as a typical outfit giving pure legal advice but can also operate like an in-house counsel, giving business advice.” 
 
“With a background in molecular biology, namesake litigator Naomi Pearce now spearheads the ensemble with supreme verve. She also receives effusive praise from clientele: “She is the perfect outside counsel to embed in the business. She is an excellent legal thinker and a delight to work with.” “Naomi is very commercially minded and will seek to achieve a settlement to avoid expensive litigation wherever possible, which is not the modus operandi of most large law practices.” 
 
A molecular biologist by trade, Jacinta Flattery-O’Brien draws judiciously upon her doctoral pedigree to provide commercially minded counsel to big names in the biopharmaceutical sector. 
 
Melbourne-based microbiology PhD Chris Vindurampulle recently joined the set. He is a frequent contributor to the research and start-up sector, providing education and mentoring on the topics of identifying, protecting and leveraging intangible assets.

Naomi Pearce says:

“I couldn’t be more proud of our leaders and the team we have assembled.  From a standing start to ranking in virtually every notable legal directory in less than 6 years is almost unheard of!  The firm and individual rankings in IAM 1000 for 2023 demonstrates the pedigree of our leaders, the calibre of the Pearce IP team, and is a direct reflection of their dedication to their craft and their clients.  I congratulate Jacinta and Chris and each and every member of the Pearce IP team for continuing to set the standard in the provision of legal/IP services in Australia.”

About Pearce IP

Pearce IP is a boutique firm offering intellectual property specialist lawyers, patent attorneys and trade mark attorneys to the pharmaceutical, biopharmaceutical and life sciences industries.  Pearce IP is the 2021 ‘Intellectual Property Team of the Year’ (Lawyers Weekly Australian Law Awards) and was shortlisted for the same award in 2022.  Pearce IP is ranked in IAM Patent 1000 and Managing IP (MIP) IP Stars, in Australasian Lawyer 5 Star Awards as a ‘5 Star’ firm, and the Legal 500 APAC Guide for Intellectual Property.  Pearce IP leaders are well recognised as leading IP practitioners.

Our leaders have been recognised in virtually every notable IP listing for their legal, patent and trade mark excellence including: IAM Patent 1000, IAM Strategy 300, MIP IP Stars, Doyles Guide, WIPR Leaders, 5 Star IP Lawyers, Women in Law Awards – Partner of the Year, Best Lawyers and Australasian Lawyer 5 Star Awards, Women in Business Law Awards – Patent Lawyer of the Year (Asia Pacific), Most Influential Lawyers (Changemaker), among other awards.

Get our Pearce IP Blogs & BioBlast® sent directly to your inbox

Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.

Our Latest News